<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-08T04:10:05Z</responseDate>
  <request identifier="oai:figshare.com:article/34054047" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34054047</identifier>
        <datestamp>2026-10-02T04:42:01Z</datestamp>
        <setSpec>category_323</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Table 3_Tophaceous gout-related carpal tunnel syndrome and flexor tendon involvement: a systematic review.xlsx</dc:title>
          <dc:creator>Ali Can Günenç (25162149)</dc:creator>
          <dc:creator>Mehmet Şefik Oruç (25162152)</dc:creator>
          <dc:subject>Surgery</dc:subject>
          <dc:subject>carpal tunnel syndrome</dc:subject>
          <dc:subject>flexor tendon</dc:subject>
          <dc:subject>gout</dc:subject>
          <dc:subject>median nerve compression</dc:subject>
          <dc:subject>systematic review</dc:subject>
          <dc:subject>tenosynovitis</dc:subject>
          <dc:subject>tophaceous gout</dc:subject>
          <dc:description>Background&lt;p&gt;Tophaceous gout is an uncommon but clinically important cause of secondary carpal tunnel syndrome (CTS), with lesions ranging from diffuse flexor tenosynovitis to intratendinous destruction and direct median nerve involvement.&lt;/p&gt;Methods&lt;p&gt;PubMed/MEDLINE, Scopus, and Web of Science Core Collection were searched through 23 July 2026, supplemented by Google Scholar, publisher-page verification, and citation searching. Human primary reports explicitly attributing CTS or wrist-level median neuropathy to gout, tophus, or monosodium urate deposition were eligible. Two reviewers independently screened records. Fifty-seven reports (27 complete/detailed and 30 limited clinical sources) formed the primary synthesis and underwent design-appropriate Joanna Briggs Institute appraisal; 12 bibliographic or translation-limited reports were retained as historical ancillary evidence. Primary reports were additionally classified post hoc by causal certainty.&lt;/p&gt;Results&lt;p&gt;Of 478 database records, 302 unique records were screened, and 69 canonical reports were included. The 57-report primary synthesis comprised 44 case reports or clinical-image reports, 12 case series, and one nonrandomized comparative study, representing at least 120 patients, 152 CTS wrists, and 146 gout-attributable wrists. Sex was reportable for 117 patients, of whom 111 (94.9%) were male. Causal certainty was Tier 1 (direct local confirmation) in 41 reports, Tier 2 (anatomically supported) in 5, and Tier 3 (explicit report-level attribution) in 11. Post hoc sensitivity analyses retaining Tier 1 + 2 (n = 46) and then Tier 1 only (n = 41) did not change the principal qualitative interpretations. Open decompression with lesion treatment was the most frequently reported operative pattern, but evidence remained insufficient to determine a preferred tendon procedure. JBI findings are reported by design; 481 item-level judgments are retained only as an audit total.&lt;/p&gt;Conclusion&lt;p&gt;Gout should be considered in atypical, acute, severe, recurrent, bilateral, or mass-associated CTS. In surgically treated reports, decompression was commonly combined with individualized management of tophaceous and tendon disease. The evidence is predominantly case-based and hypothesis-generating and is insufficient to define a validated treatment pathway or preferred tendon procedure.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-02T04:42:01Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fsurg.2026.1948883.s002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Table_3_Tophaceous_gout-related_carpal_tunnel_syndrome_and_flexor_tendon_involvement_a_systematic_review_xlsx/34054047</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
